We are live on ! Find out more
PC

PointState Capital Portfolio holdings

AUM $7.9B
1-Year Est. Return 42.31%
This Fund
S&P 500
This Quarter Est. Return
+7.4%
1 Year Est. Return
+42.31%
3 Year Est. Return
+142.91%
5 Year Est. Return
+261%
10 Year Est. Return
+1,945.58%
AUM
$4.85B
AUM Growth
+$1.14B
Cap. Flow
+$1.07B
Cap. Flow %
22.01%
Top 10 Hldgs %
53.88%
Holding
153
New
63
Increased
23
Reduced
14
Closed
45

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$356M
2
AMZN icon
Amazon
AMZN
+$325M
3
AVGO icon
Broadcom
AVGO
+$218M
4
MON
Monsanto Co
MON
+$163M
5
STZ icon
Constellation Brands
STZ
+$155M

Top Sells

Rank Stock Value
1
LYB icon
LyondellBasell Industries
LYB
+$371M
2
AGN
Allergan plc
AGN
+$207M
3
LNG icon
Cheniere Energy
LNG
+$195M
4
CHTR icon
Charter Communications
CHTR
+$153M
5
MCD icon
McDonald's
MCD
+$129M

Sector Composition

Rank Sector Weight
1 Healthcare 26.94%
2 Energy 13.27%
3 Communication Services 10.39%
4 Technology 9.49%
5 Consumer Discretionary 8.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RCL icon
126
Royal Caribbean
RCL
$86.5B
– –
-52,500
Closed -$4.31M
SKX
127
DELISTED
Skechers
SKX
– –
-50,600
Closed -$1.54M
SRPT icon
128
CALL
Sarepta Therapeutics
SRPT
$1.64B
– –
-87,000
Closed -$1.7M
STZ icon
129
PUT
Constellation Brands
STZ
$22.5B
– –
-35,000
Closed -$5.29M
W icon
130
Wayfair
W
$11.8B
– –
-50,000
Closed -$2.16M
WLK icon
131
Westlake Corp
WLK
$9.26B
– –
-274,603
Closed -$12.7M
XBI icon
132
State Street SPDR S&P Biotech ETF
XBI
$10B
– –
-19,200
Closed -$992K
XLV icon
133
State Street Health Care Select Sector SPDR ETF
XLV
$42.9B
– –
-3,700
Closed -$251K
LUMO
134
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
– –
-30,589
Closed -$5.01M
MRO
135
DELISTED
Marathon Oil Corporation
MRO
– –
-592,000
Closed -$6.59M
ICPT
136
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
– –
-155,000
Closed -$19.9M
RDUS
137
DELISTED
Radius Health, Inc.
RDUS
– –
-130,000
Closed -$4.09M
CORV
138
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
– –
-606,060
Closed -$2.48M
MDCO
139
DELISTED
Medicines Co
MDCO
– –
-280,000
Closed -$8.9M
LOXO
140
DELISTED
Loxo Oncology, Inc
LOXO
– –
-280,000
Closed -$7.66M
SONC
141
PUT
DELISTED
Sonic Corp
SONC
– –
-50,000
Closed -$1.76M
BWLD
142
PUT
DELISTED
Buffalo Wild Wings, Inc.
BWLD
– –
-30,000
Closed -$4.44M
MACK
143
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
– –
-44,485
Closed -$2.93M
AXLL
144
DELISTED
AXIALL CORP COM STK (DE)
AXLL
– –
-140,400
Closed -$3.07M
CPXX
145
DELISTED
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
– –
-100,000
Closed -$1.1M
WLL
146
DELISTED
Whiting Petroleum Corporation
WLL
– –
-3,333
Closed -$7.98M
MDVN
147
DELISTED
MEDIVATION, INC.
MDVN
– –
-2,067,361
Closed -$95.1M
TWC
148
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
– –
-57,015
Closed -$11.7M
ANAC
149
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
– –
-325,000
Closed -$17.4M
2 3 4 5
6

Similar funds

CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
IMRF
Illinois Municipal Retirement Fund Oak Brook, Illinois $7.86B AUM 24.45% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
CMTU
Capital Markets Trading (UK) London, United Kingdom $7.95B AUM 85.98% 1-Year Est. Return
PGFC
Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return
EGM
Engineers Gate Manager New York $8B AUM 17.32% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
MT
Midwest Trust Overland Park, Kansas $8.02B AUM 23.54% 1-Year Est. Return

PointState Capital's Q2 2016 Portfolio in Review

As of Q2 2016, PointState Capital held 153 positions worth $4.85B, up 31% from $3.71B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

PointState Capital deployed $1.07B of net new capital in Q2 2016, opening 63 new positions and adding to 23 existing holdings. Its largest new stake was Broadcom: 14,318,500 shares worth $223M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 38% a quarter earlier, followed by Energy and Communication Services.

On the sell side, the largest reduction was Allergan plc, an estimated $207M trimmed.

  • PointState Capital's largest Q2 2016 buy was Broadcom: 14,318,500 shares worth $223M.
  • PointState Capital added most to Teva Pharmaceuticals in Q2 2016, an estimated $356M increase.
  • PointState Capital's biggest Q2 2016 reduction was Allergan plc, cutting an estimated $207M.
  • PointState Capital fully exited LyondellBasell Industries in Q2 2016, selling an estimated $371M.
  • PointState Capital's ten largest holdings make up 54% of its $4.85B portfolio in Q2 2016.
  • PointState Capital opened 63 new positions and closed 45 in Q2 2016.
  • PointState Capital's portfolio value rose 31% quarter-over-quarter to $4.85B.

Based on PointState Capital's 13F filing for Q2 2016, filed 15 Aug 2016.